Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 13;14(5):piaf041.
doi: 10.1093/jpids/piaf041.

A Prospective Evaluation of a Three-Gene Host Response Signature to Classify Tuberculosis Severity in Children

Affiliations

A Prospective Evaluation of a Three-Gene Host Response Signature to Classify Tuberculosis Severity in Children

Brittney Sweetser et al. J Pediatric Infect Dis Soc. .

Abstract

Background: Children with non-severe TB may benefit from short-course treatment, but point-of-care tools are needed to stratify disease severity. We prospectively evaluated the Cepheid Xpert MTB-Host Response (HR) prototype cartridge for distinguishing TB severity in children with pulmonary TB (PTB) in The Gambia and Uganda.

Methods: We included children <15 with microbiologically confirmed or clinically diagnosed unconfirmed PTB. Severity was defined using the World Health Organization (WHO) guidelines for a four-month, drug-susceptible regimen. Capillary or venous blood was tested with the HR cartridge for PCR-based detection of 3 mRNA genes and calculation of a TB score from cycle thresholds. We generated receiver operating characteristic curves with the TB score to classify severe TB and assessed if Xpert-HR could achieve the WHO target accuracy for treatment optimization (≥90% sensitivity, ≥70% specificity).

Results: Among 106 children, the median age was 4 years (IQR 1-7), 56.6% were female, and 13.2% were living with HIV. In all children with PTB, Xpert-HR achieved an AUC of 0.67 (95% CI 0.55-0.78), with 89.3% sensitivity (95% CI 71.8-97.7) and 29.5% specificity (95% CI 19.7-40.9, cutoff ≤ -0.60). By confirmation status, Xpert-HR approached the target accuracy in children with Confirmed TB, with 62.5% specificity (95% CI 24.5-91.5) at 91.7% sensitivity (95% CI 61.5-99.8, cut-off ≤ -1.349). Among children with Unconfirmed TB, specificity was lower (24.3%, 95% CI 14.8-36.0) at 93.8% sensitivity (95% CI 69.8-99.8, cutoff ≤ -0.450). Target accuracy was almost achieved in children 5-9 regardless of confirmation status (100% sensitivity [95% CI 71.5-100], 66.7% specificity [95% CI 43.0-85.4], cutoff ≤ -1.35), but specificity (28.2%, 95% CI 18.6-39.5) was lower for children < 5 (92.9% sensitivity, 95% CI 76.5-99.1, cutoff ≤ -0.550).

Conclusions: Xpert-HR approached the target accuracy to stratify PTB severity in older children and those with Confirmed TB but had lower specificity in children with Unconfirmed TB. Child-specific signatures may be needed to improve performance in younger children with paucibacillary disease.

Keywords: child; gene signature; host-response; severity; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Participant Flowchart.
Figure 2.
Figure 2.
Box-and-Whisker Plots of Xpert-HR TB Scores by TB Severity in Children. The box represents the interquartile range and the horizontal line within the box marks the median. Circles represent outliers. ** P < 0.01.
Figure 3.
Figure 3.
Receiver Operating Characteristic Curve for the Xpert-HR TB Score on TB Severity for Children (a) overall, (b) with confirmed TB, and (c) with unconfirmed TB. The dot on the curve represents the cutoff value closest to 90% sensitivity. The dashed lines denote the sensitivity and specificity at this cutoff.

References

    1. World Health Organization. Global tuberculosis report 2024; 2024:68.
    1. Marais BJ, Gie RP, Schaaf HS, et al.The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392–402. - PubMed
    1. Shingadia D, Novelli V.. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis. 2003;3:624–632. https://doi.org/10.1016/s1473-3099(03)00771-0 - DOI - PubMed
    1. Li Y, Zhu Y, Zhong Q, Zhang X, Shu M, Wan C.. Serious adverse reactions from anti-tuberculosis drugs among 599 children hospitalized for tuberculosis. Pediatr Infect Dis J. 2017;36:720–725. https://doi.org/10.1097/INF.0000000000001532 - DOI - PubMed
    1. World Health Organization. WHO operational handbook on tuberculosis. In: Module 5: Management of Tuberculosis in Children and Adolescents. World Health Organization; 2022. - PubMed

LinkOut - more resources